These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 16928714
1. Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis. Barlow G, Nathwani D, Williams F, Ogston S, Winter J, Jones M, Slane P, Myers E, Sullivan F, Stevens N, Duffey R, Lowden K, Davey P. Thorax; 2007 Jan; 62(1):67-74. PubMed ID: 16928714 [Abstract] [Full Text] [Related]
2. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia. Lee RW, Lindstrom ST. Respirology; 2007 Sep; 12(5):754-8. PubMed ID: 17875067 [Abstract] [Full Text] [Related]
3. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Arch Intern Med; 2004 Mar 22; 164(6):637-44. PubMed ID: 15037492 [Abstract] [Full Text] [Related]
4. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS. Clin Ther; 2010 Feb 22; 32(2):293-9. PubMed ID: 20206787 [Abstract] [Full Text] [Related]
5. Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia. Cortoos PJ, Gilissen C, Laekeman G, Peetermans WE, Leenaers H, Vandorpe L, Simoens S. Scand J Infect Dis; 2013 Mar 22; 45(3):219-26. PubMed ID: 23113827 [Abstract] [Full Text] [Related]
6. Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia. Chalmers JD, Singanayagam A, Akram AR, Choudhury G, Mandal P, Hill AT. J Antimicrob Chemother; 2011 Feb 22; 66(2):416-23. PubMed ID: 21081545 [Abstract] [Full Text] [Related]
7. Management of community-acquired pneumonia by trained family general practitioners. Potena A, Simoni M, Cellini M, Cartabellotta A, Ballerin L, Piattella M, Putinati S. Int J Tuberc Lung Dis; 2008 Jan 22; 12(1):19-25. PubMed ID: 18173872 [Abstract] [Full Text] [Related]
8. [Cost-effectiveness analysis of ambulatory treatment for adult patients with community-acquired pneumonia: according to Japanese Respiratory Society guidelines]. Morimoto T, Koyama H, Shimbo T, Fukui T. Nihon Kokyuki Gakkai Zasshi; 2002 Jan 22; 40(1):17-25. PubMed ID: 11925912 [Abstract] [Full Text] [Related]
9. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Am J Med; 2006 Oct 22; 119(10):865-71. PubMed ID: 17000218 [Abstract] [Full Text] [Related]
18. Efficacy of clinical guideline implementation to improve the appropriateness of chest physiotherapy prescription among inpatients with community-acquired pneumonia. Guessous I, Cornuz J, Stoianov R, Burnand B, Fitting JW, Yersin B, Lamy O. Respir Med; 2008 Sep 22; 102(9):1257-63. PubMed ID: 18619824 [Abstract] [Full Text] [Related]
19. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB). Lavoie F, Blais L, Castilloux AM, Scalera A, LeLorier J. Can J Clin Pharmacol; 2005 Sep 22; 12(2):e212-7. PubMed ID: 15998960 [Abstract] [Full Text] [Related]
20. Effect of a simple educational intervention on the hospital management of community-acquired pneumonia. Serisier DJ, Bowler SD. Respirology; 2007 May 22; 12(3):389-93. PubMed ID: 17539843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]